Chelsey Nicole Keathley, MSW | |
351 New River Ranch Dr, Fayetteville, WV 25840-6220 | |
(304) 574-1058 | |
Not Available |
Full Name | Chelsey Nicole Keathley |
---|---|
Gender | Female |
Speciality | Social Worker - Clinical |
Location | 351 New River Ranch Dr, Fayetteville, West Virginia |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1710665658 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | (West Virginia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Chelsey Nicole Keathley, MSW 150 Ridge Street, Mount Hope, WV 25880 Ph: (304) 654-8079 | Chelsey Nicole Keathley, MSW 351 New River Ranch Dr, Fayetteville, WV 25840-6220 Ph: (304) 574-1058 |
News Archive
Researchers in the Center for Cell and Gene Therapy at Baylor College of Medicine, Houston Methodist and Texas Children's Hospital have found that a single dose of an otherwise harmless drug can safely control the severe and often lethal side effects associated with haploidentical stem cell transplantation.
Chicago Tribune: "If you listen to hospital lobbyists in Washington, the industry teeters on the brink of financial ruin, depending on how health care reform plays out. But the rhetoric does not match the balance sheets of some of Chicago's largest hospital operators.
Air quality has been associated with numerous adverse health outcomes from asthma to pre-term birth. Researchers at University of Utah Health found women living along the Wasatch Front - the most populous region in the state of Utah - had a higher risk (16 percent) of miscarriage following short-term exposure to elevated air pollution. The results are available online on December 5 in the journal Fertility and Sterility.
OncoSec Medical Incorporated, a company developing DNA-based intratumoral cancer immunotherapies, today announced enrollment of the first patient into the Phase II Investigator Sponsored Trial led by the University of California, San Francisco to assess the anti-tumor activity, safety, and tolerability of the combination of OncoSec's investigational therapy, ImmunoPulse IL-12, and Merck's approved anti-PD-1 agent, KEYTRUDA (pembrolizumab), in patients with unresectable metastatic melanoma.
› Verified 3 days ago
Joann Inglut Tweeddale, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 100 2nd Ave, Fayetteville, WV 25840 Phone: 304-573-1523 | |
Mrs. Lorrie Jill Hudson, MSW, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: Rr 2 Box 355k, Fayetteville, WV 25840 Phone: 304-574-1585 | |
Heather Renee Collins, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 209 W Maple Ave, Fayetteville, WV 25840 Phone: 304-574-2100 | |
Mark Vincent Sundstrom, M.S.,LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 209 W Maple Ave, Fayetteville, WV 25840 Phone: 304-574-2100 Fax: 304-574-2151 |